We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£103.81
Springer TRAIL, Fas Ligand, TNF and TLR3 in Cancer: 12 (Resistance to Targeted Anti-Cancer Therapeutics, 12)
Price data last checked 137 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
About as cheap as it gets. The only time it was cheaper was 1 year ago.
£104 today · all-time low £103 (Jun 2024) · usually the usual
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 594 days • 594 data points (No recent data available)
Price Distribution
Price distribution over 594 days • 4 price levels
Price Analysis
Most common price: £107 (270 days, 45.5%)
Price range: £104 - £113
Price levels: 4 different prices over 594 days
Description
Product Specifications
- Brand
- Springer
- Format
- Hardcover
- ASIN
- 3319568043
- Domain
- Amazon UK
- Release Date
- 10 July 2017
- Listed Since
- 09 March 2017
Barcode
No barcode data available
Similar Products You Might Like
Death Receptors and Cognate Ligands in Cancer: 49 (Results and Problems in Cell Differentiation, 49)
Springer
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)
Humana
Death Receptors and Cognate Ligands in Cancer: 49 (Results and Problems in Cell Differentiation, 49)
Springer
Springer - Molecular Mechanisms of Tumor Cell Resistance
Springer
TRAIL, Fas Ligand, TNF and TLR3 in Cancer: 12 (Resistance to Targeted Anti-Cancer Therapeutics, 12)
Springer
Advances in Cancer Research: Vol. 74: Volume 74
Academic Press
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
Humana
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
CRC Press
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
Humana
Springer - Immunotherapy of Cancer: An Innovative Treatment
Springer
Cell Death Signaling in Cancer Biology and Treatment (Cell Death in Biology and Diseases)
Humana
Apoptosis in Cancer Pathogenesis and Anti-cancer Therapy: New Perspectives and Opportunities: 930 (Advances in Experimental Medicine and Biology, 930)
Springer
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Springer
Cancer Immunology: A Translational Medicine Context
Springer
Inflammation and Immunity in Cancer
Springer
Molecular Targeting and Signal Transduction: 119 (Cancer Treatment and Research, 119)
Springer
Immuno-Oncology: Cellular and Translational Approaches (Methods in Pharmacology and Toxicology)
Humana
Advances in Cancer Research (Volume 75)
Academic Press
Targeted Cancer Immune Therapy
Springer
Signal Transduction in Cancer: 115 (Cancer Treatment and Research, 115)
Springer
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
CRC Press
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
Humana
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
Springer
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
Springer